| 000 | 01303 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516080202.0 | ||
| 264 | 0 | _c20120604 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/092986712803414312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobak, E | |
| 245 | 0 | 0 |
_aNovel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2012 |
||
| 300 |
_a438-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemistry |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xchemistry |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xchemistry |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aRobak, T | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 19 _gno. 3 _gp. 438-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986712803414312 _zAvailable from publisher's website |
| 999 |
_c21546338 _d21546338 |
||